Torrent [TORNTPHARM] vs Dr. Reddy's [DRREDDY] Detailed Stock Comparison

Torrent

NSE
Loading...

Dr. Reddy's

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Torrent wins in 11 metrics, Dr. Reddy's wins in 9 metrics, with 0 ties. Torrent appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricTorrentDr. Reddy'sBetter
P/E Ratio (TTM)59.9419.12Dr. Reddy's
Price-to-Book Ratio15.763.09Dr. Reddy's
Debt-to-Equity Ratio42.8113.75Dr. Reddy's
PEG Ratio3.029.93Torrent
EV/EBITDA32.1711.96Dr. Reddy's
Profit Margin (TTM)16.92%16.99%Dr. Reddy's
Operating Margin (TTM)26.15%20.50%Torrent
EBITDA Margin (TTM)26.15%20.50%Torrent
Return on Equity25.18%17.71%Torrent
Return on Assets (TTM)12.75%9.71%Torrent
Free Cash Flow (TTM)$19.73B$12.03BTorrent
Dividend Yield17.47%11.59%Torrent
1-Year Return4.98%-3.60%Torrent
Price-to-Sales Ratio (TTM)10.113.29Dr. Reddy's
Enterprise Value$1,222.19B$1,068.90BTorrent
EV/Revenue Ratio10.333.20Dr. Reddy's
Gross Profit Margin (TTM)75.26%56.91%Torrent
Revenue per Share (TTM)$350$401Dr. Reddy's
Earnings per Share (Diluted)$58.98$68.07Dr. Reddy's
Beta (Stock Volatility)0.130.32Torrent
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Torrent vs Dr. Reddy's Stock Performance Analysis

Loading Price Chart...

Torrent
Dr. Reddy's
Torrent Stock Overview | Dr. Reddy's Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Torrent-0.12%3.52%-0.80%15.49%11.75%6.94%
Dr. Reddy's0.54%0.05%1.86%-1.25%7.53%-4.94%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Torrent4.98%134.38%29.77%144.93%1,180.53%4,939.84%
Dr. Reddy's-3.60%50.08%27.29%53.72%338.31%1,428.00%

News Based Sentiment: Torrent vs Dr. Reddy's

Torrent

News based Sentiment: POSITIVE

Torrent Pharmaceuticals had a strong month marked by strategic investments in renewable energy, positive analyst revisions, and proactive financial management. While some short-term stock volatility was observed, the overall narrative points towards a strengthening long-term position and positive investment outlook.

View Torrent News Sentiment Analysis

Dr. Reddy's

News based Sentiment: MIXED

September presented a mixed bag for Dr. Reddy's, with positive developments like the Stugeron acquisition and Tegoprazan launch offset by FDA observations and a significant stake reduction by Goldman Sachs. While analyst ratings remain positive, the regulatory uncertainty and institutional selling create a cautious outlook.

View Dr. Reddy's News Sentiment Analysis

Performance & Financial Health Analysis: Torrent vs Dr. Reddy's

MetricTORNTPHARMDRREDDY
Market Information
Market Cap i₹1.21T₹1.11T
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i140,4031,198,227
90 Day Avg. Volume i211,8631,292,306
Last Close₹3,651.50₹1,308.40
52 Week Range₹2,886.45 - ₹3,787.90₹1,020.00 - ₹1,405.90
% from 52W High-3.60%-6.94%
All-Time High₹3,787.90 (Jul 30, 2025)₹1,421.49 (Aug 19, 2024)
% from All-Time High-3.60%-7.96%
Growth Metrics
Quarterly Revenue Growth0.11%0.11%
Quarterly Earnings Growth0.20%0.02%
Financial Health
Profit Margin (TTM) i0.17%0.17%
Operating Margin (TTM) i0.26%0.21%
Return on Equity (TTM) i0.25%0.18%
Debt to Equity (MRQ) i42.8113.75
Cash & Liquidity
Book Value per Share (MRQ)₹224.28₹420.56
Cash per Share (MRQ)₹20.33₹80.12
Operating Cash Flow (TTM) i₹27.02B₹52.56B
Levered Free Cash Flow (TTM) i₹19.11B₹14.23B
Dividends
Last 12-Month Dividend Yield i17.47%11.59%
Last 12-Month Dividend i₹552.76₹146.30

Valuation & Enterprise Metrics Analysis: Torrent vs Dr. Reddy's

MetricTORNTPHARMDRREDDY
Price Ratios
P/E Ratio (TTM) i59.9419.12
Forward P/E i39.713.79
PEG Ratio i3.029.93
Price to Sales (TTM) i10.113.29
Price to Book (MRQ) i15.763.09
Market Capitalization
Market Capitalization i₹1.21T₹1.11T
Enterprise Value i₹1.22T₹1.07T
Enterprise Value Metrics
Enterprise to Revenue i10.333.20
Enterprise to EBITDA i32.1711.96
Risk & Other Metrics
Beta i0.130.32
Book Value per Share (MRQ) i₹224.28₹420.56

Financial Statements Comparison: Torrent vs Dr. Reddy's

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)TORNTPHARMDRREDDY
Revenue/Sales i₹31.28B₹85.45B
Cost of Goods Sold i₹7.74B₹36.83B
Gross Profit i₹23.54B₹48.63B
Research & Development iN/A₹6.24B
Operating Income (EBIT) i₹8.31B₹16.84B
EBITDA i₹9.95B₹23.41B
Pre-Tax Income i₹7.38B₹19.05B
Income Tax i₹1.90B₹4.95B
Net Income (Profit) i₹5.48B₹14.10B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)TORNTPHARMDRREDDY
Cash & Equivalents i₹5.73B₹14.65B
Total Current Assets i₹56.23B₹250.11B
Total Current Liabilities i₹47.17B₹130.39B
Long-Term Debt i₹13.38B₹7.86B
Total Shareholders Equity i₹75.91B₹337.17B
Retained Earnings iN/A₹315.79B
Property, Plant & Equipment i₹2.99B₹0

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)TORNTPHARMDRREDDY
Operating Cash Flow iN/A₹27.79B
Capital Expenditures iN/A₹-7.67B
Free Cash Flow iN/A₹10.75B
Debt Repayment iN/A₹-253.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricTORNTPHARMDRREDDY
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i140,4031,198,227
Average Daily Volume (90 Day) i211,8631,292,306
Shares Outstanding i338.45M832.00M
Float Shares i103.96M591.38M
% Held by Insiders i0.71%0.29%
% Held by Institutions i0.15%0.51%

Dividend Analysis & Yield Comparison: Torrent vs Dr. Reddy's

MetricTORNTPHARMDRREDDY
Last 12-Month Dividend i₹552.76₹146.30
Last 12-Month Dividend Yield i17.47%11.59%
3-Year Avg Annual Dividend i₹198.92₹49.30
3-Year Avg Dividend Yield i3.27%3.74%
3-Year Total Dividends i₹596.76₹147.90
Ex-Dividend DateJun 20, 2025Jul 10, 2025